Just a moment, the page is loading...

*EISAI-E2007-J000-335




A Double-blind, Placebo-controlled, Parallel-group Study With an Open-label Extension Phase to Evaluate the Efficacy and Safety of Perampanel (E2007) Administered as an Adjunctive Therapy in Subjects With Refractory Partial-onset Seizures
perampanel
E2007-J000-335
NCT01618695
Partial-onset Seizures
Phase 3
 
No restrictions.
November 2018